medical oncology

Exploring international differences in ovarian cancer treatment: a comparison of clinical practice guidelines and patterns of care
Charles H Norell, John Butler, Rhonda Farrell, Alon Altman, James Bentley, Citadel J Cabasag, Paul A Cohen, Scott Fegan, Michael Fung-Kee-Fung, Charlie Gourley, Neville F Hacker, Louise Hanna, Claus Kim Høgdall, Gunnar Kristensen, Janice Kwon, Orla McNally, Gregg Nelson, Andy Nordin, Dearbhaile O'Donnell, Tine Schnack, Peter H Sykes, Ewa Zotow, Samantha Harrison

International Journal of Gynecologic Cancer Jul 2020, ijgc-2020-001403; DOI: 10.1136/ijgc-2020-001403
Exploiting replicative stress in gynecological cancers as a therapeutic strategy
Natalie YL Ngoi, Vignesh Sundararajan, David SP Tan

International Journal of Gynecologic Cancer Aug 2020, 30 (8) 1224-1238; DOI: 10.1136/ijgc-2020-001277
Impact of PD-L1 and T-cell inflamed gene expression profile on survival in advanced ovarian cancer
Estrid Høgdall, Claus Høgdall, Thao Vo, Wei Zhou, Lingkang Huang, Matthew Marton, Stephen M Keefe, Michael Busch-Sørensen, Sarah M. Sørensen, Jeanette Georgsen, Else Mejlgaard, Lotte Nedergaard, Torben Steiniche

International Journal of Gynecologic Cancer Jul 2020, 30 (7) 1034-1042; DOI: 10.1136/ijgc-2019-001109
Letrozole in the management of advanced ovarian cancer: an old drug as a new targeted therapy
Claudia Marchetti, Francesca De Felice, Raffaella Ergasti, Giovanni Scambia, Anna Fagotti

International Journal of Gynecologic Cancer Jul 2020, 30 (7) 1058-1064; DOI: 10.1136/ijgc-2019-001128
Use of PROM during follow-up of patients with ovarian cancer: the PROMova study protocol
Anette Stolberg Kargo, Angela Coulter, Kristina Lindemann, Pernille Tine Jensen, Niels Henrik Hjøllund, Berit Jul Mosgaard, Karina Dahl Steffensen

International Journal of Gynecologic Cancer Jun 2020, ijgc-2020-001528; DOI: 10.1136/ijgc-2020-001528
Delays from neoadjuvant chemotherapy to interval debulking surgery and survival in ovarian cancer
Ying L Liu, Qin C Zhou, Alexia Iasonos, Olga T Filippova, Dennis S Chi, Oliver Zivanovic, Yukio Sonoda, Ginger Gardner, Vance Broach, Roisin OCearbhaill, Jason A Konner, Carol A Aghajanian, Kara Long, William Tew

International Journal of Gynecologic Cancer Jun 2020, ijgc-2019-000989; DOI: 10.1136/ijgc-2019-000989
Discrepancy in calculated and measured glomerular filtration rates in patients treated with PARP inhibitors
Graziela Zibetti Dal Molin, Shannon Neville Westin, Pavlos Msaouel, Larissa M Gomes, Andrea Dickens, Robert L Coleman

International Journal of Gynecologic Cancer Jan 2020, 30 (1) 89-93; DOI: 10.1136/ijgc-2019-000714
Management of recurrent ovarian cancer: when platinum-based regimens are not a therapeutic option
Alice Bergamini, Luca Bocciolone, Andrei Fodor, Massimo Candiani, Giorgia Mangili

International Journal of Gynecologic Cancer Nov 2019, 29 (9) 1431-1436; DOI: 10.1136/ijgc-2019-000624
Treatment patterns and associated factors in patients with advanced epithelial ovarian cancer: a population-based study
Myrte Zijlstra, Maite Timmermans, Heidi Fransen, Maaike van der Aa, An Reyners, Natasja Raijmakers, Lonneke van de Poll-Franse

International Journal of Gynecologic Cancer Jul 2019, 29 (6) 1032-1037; DOI: 10.1136/ijgc-2019-000489
Poly-ADP-ribose polymerase inhibitor use in ovarian cancer: expanding indications and novel combination strategies
Emily Hinchcliff, Shannon Neville Westin, Graziela Dal Molin, Christopher J LaFargue, Robert L. Coleman

International Journal of Gynecologic Cancer Jun 2019, 29 (5) 956-968; DOI: 10.1136/ijgc-2019-000499

Log in using your username and password

Main menu

Log in using your username and password

You are here

medical oncology